# Alfredo Addeo

Source: https://onco.cc/people/alfredo-addeo/  
OnCo record `alfredo-addeo` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Thoracic oncologist who heads the Oncology Division at Geneva University Hospitals.

## Summary

Alfredo Addeo is Head of the Oncology Division at Geneva University Hospitals (HUG). A medical oncologist specialising in thoracic oncology and immunotherapy, he has published widely on immune checkpoint inhibitors, biomarkers of response and the design of clinical trials in non-small-cell lung cancer, small-cell lung cancer and mesothelioma. His papers include the SAKK 19/17 safety analysis of first-line durvalumab in PD-L1 positive advanced non-small-cell lung cancer in patients with a performance status of 2, a Swiss cohort study of immune checkpoint inhibitors in relapsed small-cell lung cancer, and a French-language review on whether to treat elderly patients with metastatic non-small-cell lung cancer with immunotherapy. He leads the division's clinical and research work in Geneva.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: leadership; clinician-scientist; lung cancer; immunotherapy
- Role: Head of Division, Oncology
- Specialisms: Thoracic oncology; Immunotherapy; Medical oncology

## Sources

- Institution profile: https://www.hug.ch/en/oncology
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Addeo+A%5BAuthor%5D

## Connected records

- cancers: [Mesothelioma](https://onco.cc/cancers/mesothelioma/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- institutions: [Geneva University Hospitals (HUG)](https://onco.cc/institutions/hug-geneva/)
- journals: [Cancer immunology, immunotherapy](https://onco.cc/journals/cancer-immunology-immunotherapy/)

---
JSON: https://onco.cc/api/v1/entities/alfredo-addeo.json